The effect of an adenosine--3'5'--monophosphate diesterase inhibitor (aminophylline) on the insulin response to glucose infusion in prediabetic and diabetic subjects.
D000328:Adult; D000628:Aminophylline / Q000494:pharmacology*; D003202:Computers, Analog; D000242:Cyclic AMP / Q000502:physiology; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology*; D005951:Glucose Tolerance Test; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects; D008297:Male; D008433:Mathematics; D008875:Middle Aged; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D011236:Prediabetic State / Q000097:blood*
D007328:Insulin; D000628:Aminophylline; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D005947:Glucose